Microbiome Therapeutics Market - Industry Dynamics, Market Size, and Opportunity Forecast to 2035

Microbiome Therapeutics Market: By Product Type (Fecal Microbiota-Based (Rebyota), Oral Live Biotherapeutic (Vowst)), Defined Consortia, Late-Phase Pipeline); Route of Administration (Oral, Rectal, Other); Indication (C. difficile Infection, Inflammatory Bowel Disease, Metabolic/Obesity, Oncology Support, CNS/ Gut-Brain); End User (Hospitals & Clinics, Specialty Pharmacies, Physician Clinics)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast For 2026–2035

The microbiome therapeutics market is estimated at USD 550.7 million in 2025 and is projected to reach USD 4,619.8 million by 2035, growing at a CAGR of 23.7% over the forecast period 2026–2035. Read More

We Are Trusted By These Great Companies!

• Last Updated: 10-Aug-2026  |  Format:  |  Report ID: AA08261926